Orient Overseas (International) Ltd
HKEX:316
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Orient Overseas (International) Ltd
HKEX:316
|
HK |
|
Eupraxia Pharmaceuticals Inc
NASDAQ:EPRX
|
CA |
Wall St Price Targets
Price Targets Summary
Orient Overseas (International) Ltd
According to Wall Street analysts, the average 1-year price target for
Orient Overseas (International) Ltd is 136.49 HKD with a low forecast of 101 HKD and a high forecast of 184.8 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Orient Overseas (International) Ltd's stock price target?
Price Target
136.49
HKD
According to Wall Street analysts, the average 1-year price target for
Orient Overseas (International) Ltd is 136.49 HKD with a low forecast of 101 HKD and a high forecast of 184.8 HKD.
What is the Revenue forecast for Orient Overseas (International) Ltd?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 2%.
What is the Gross Profit forecast for Orient Overseas (International) Ltd?
Projected CAGR
17%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 17%.
What is the Operating Income forecast for Orient Overseas (International) Ltd?
Projected CAGR
-36%
Over the last 14 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 3 years is -36%.
What is the Pre-Tax Income forecast for Orient Overseas (International) Ltd?
Projected CAGR
-14%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 17%. The projected CAGR for the next 3 years is -14%.
What is the Net Income forecast for Orient Overseas (International) Ltd?
Projected CAGR
-24%
Over the last 14 years, the compound annual growth rate for Net Income has been 16%. The projected CAGR for the next 3 years is -24%.